Journals / Turkish Journal of Medical Sciences / 2010 / Cilt: 40 - Sayı: 2

Assessment of procalcitonin and other inflammatory markers in peritoneal dialysis-related peritonitis*

Pages
199–206
Publication Date
2010-02-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The sensitivity and specificity of PCT were not superior to CRP in peritoneal dialysis-related peritonitis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:It is demonstrated that in end-stage renal failure without an infectious pathology conventional laboratory parameters such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) or other acute-phase proteins increase non-specifically.
📊
Key Findings & Data:We aimed to evaluate procalcitonin (PCT) and other inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) in patients with continuous ambulatory peritoneal dialysis (CAPD)-related peritonitis.
💡
Conclusion & Impact:The sensitivity and specificity of PCT were not superior to CRP in peritoneal dialysis-related peritonitis.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Key words: Procalcitonin · C-reactive protein · peritonitis

Abstract

It is demonstrated that in end-stage renal failure without an infectious pathology conventional laboratory parameters such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) or other acute-phase proteins increase non-specifically. We aimed to evaluate procalcitonin (PCT) and other inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) in patients with continuous ambulatory peritoneal dialysis (CAPD)-related peritonitis. Materials and methods: A case-control study was conducted in a 600-bed tertiary hospital. Fifty patients with CAPD-related peritonitis constituting the study group and 50 CAPD patients without infection as the control group were included in the study between February 2006 and July 2006. Baseline serum WBC count, PCT, ESR, and CRP levels were determined in all patients. Results: Fifty-six peritonitis episodes were detected in 50 patients. The mean ESR and CRP levels were significantly higher in the study group (P < 0.001). PCT levels were >0.5 ng/mL in 21 of the 50 patients (42%) in the study group and 8 of the 50 patients (16%) in the control group. The positive predictive value was 100% for CRP levels higher than 5 mg/dL and PCT levels higher than 2 ng/mL. The sensitivities were calculated as 40% and 14% by the same cut-off levels for CRP and PCT, respectively. Conclusion: Serum CRP level is a significant and valuable parameter for detecting inflammation, and determining a new cut-off point for CRP will increase its usefulness in patients with CAPD-related peritonitis. The sensitivity and specificity of PCT were not superior to CRP in peritoneal dialysis-related peritonitis.

Özet

It is demonstrated that in end-stage renal failure without an infectious pathology conventional laboratory parameters such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) or other acute-phase proteins increase non-specifically. We aimed to evaluate procalcitonin (PCT) and other inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) in patients with continuous ambulatory peritoneal dialysis (CAPD)-related peritonitis. Materials and methods: A case-control study was conducted in a 600-bed tertiary hospital. Fifty patients with CAPD-related peritonitis constituting the study group and 50 CAPD patients without infection as the control group were included in the study between February 2006 and July 2006. Baseline serum WBC count, PCT, ESR, and CRP levels were determined in all patients. Results: Fifty-six peritonitis episodes were detected in 50 patients. The mean ESR and CRP levels were significantly higher in the study group (P < 0.001). PCT levels were >0.5 ng/mL in 21 of the 50 patients (42%) in the study group and 8 of the 50 patients (16%) in the control group. The positive predictive value was 100% for CRP levels higher than 5 mg/dL and PCT levels higher than 2 ng/mL. The sensitivities were calculated as 40% and 14% by the same cut-off levels for CRP and PCT, respectively. Conclusion: Serum CRP level is a significant and valuable parameter for detecting inflammation, and determining a new cut-off point for CRP will increase its usefulness in patients with CAPD-related peritonitis. The sensitivity and specificity of PCT were not superior to CRP in peritoneal dialysis-related peritonitis.

🔖

Cite This Article

ÖZTÜRK, R., YILMAZ, G. R., BULUT, C., PARPUCU, H., KINIKLI, S., DURANAY, M., DEMİRÖZ, A. P. (2010). Assessment of procalcitonin and other inflammatory markers in peritoneal dialysis-related peritonitis*. Turkish Journal of Medical Sciences, Cilt: 40 - Sayı: 2, 199–206. https://ajindex.com/articles/723614

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Bathon J, Graves Jens P, Hamrick R, Mayes M. The erytrocite sedimentation rate in end-stage renal failure. Am J Kidney Dis 1987; 10: 34-40. 2. Haubitz M, Schulze M, Koch KM. Increase of C-reactive protein serum values following haemodialysis. Nephrol Dial Transplant 1990; 5: 5000-3.
  2. Schmidt M, Burchardi C, Sitter T, Held E, Schiffl H. Procalcitonin in patients undergoing chronic hemodialysis. Nephron 2000; 84: 187-8. 9. D’Intini V, Bordoni V, Fortunato A, Galloni E, Carta M, Galli F et al. Longitudinal study of apoptosis in chronic uremic patients. Semin Dial 2003; 16: 467-73.
  3. Opatrna S, Klaboch J, Opatrny Jr K, Holubec L, Tomsu M, Sefrna F et al. Procalcitonin levels in peritoneal dialysis patients. Perit Dial Int 2005; 25: 470-2.
  4. Levison ME, Bush LM. Peritonitis and Intraperitoneal Abscesses. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 6thed. USA: Churchill Livingstone; 2005. p.927-51.
  5. Gokal R, Ramos JM, Francis DM, Ferner RE, Goodship TH, Proud G et al. Peritonitis in continuous ambulatory peritoneal dialysis. Laboratory and clinical studies. Lancet 1982; 2: 1388- 91. Knight KR, Polak A, Crump J, Maskell R. Laboratory diagnosis and oral treatment of CAPD-related peritonitis. Lancet 1982; ii: 1027-30. Mion CM. Practice use of peritoneal dialysis. In: Drukker N, Parsons FM, Maher JF, editors. Replacement of renal function by dialysis. 2nded. Boston: Martinus Nijhoff; 1983. p.457-92.
  6. Ramos JM, Gokal R, Siamopoulos K, Ward MK, Wilkinson R, Kerr DNS. Continuous ambulatory peritoneal dialysis: three years experience. Q J Med 1983; 52: 165-86.
  7. Lindblad AS, Nowak JW, Nolph KD. Continuous ambulatory peritoneal dialysis in the USA: Final report of the National CAPD Registry 1981-1988. Dordrecht: Kluwer Academic Publishers; 1989.
  8. Maiorca R, Vonesh EF, Cavalli P, De Vecchi A, Giangrande A, La Greca G et al. A multi-center, selection-adjusted comparison of patient and technique survivals on CAPD and haemodialysis. Perit Dial Int 1991; 11: 118-127
  9. Golper TA, Geerlings W, Selwood NH, Brunner FP, Wing AJ. Peritoneal dialysis result in the EDTA Registry In: Nolph KD, editor. Peritoneal Dialysis. Dordrecht: Kluwer Academic Publishers; 1989. p.4114-428.
  10. Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reactive protein and risk of death in chronic dialysis patients. Nephrol Dial Transplant 1999; 14: 1956-60.
  11. Sitter T, Schmidt M, Schneider S, Schiffl H. Differential diagnosis of bacterial infection and inflammatory response i